Plasma proteomic-based output complements tissue PD-L1 expression levels as a tool to assist therapeutic decisions for non-small cell lung cancer (NSCLC) patients BINYAMINA, Israel, May 25, 2023 ...
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results